{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T02:29:00Z","timestamp":1775874540126,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/ja.2016.77","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T06:22:28Z","timestamp":1467786148000},"page":"122-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antibiotic combinations for controlling colistin-resistant Enterobacter cloacae"],"prefix":"10.1038","volume":"70","author":[{"given":"Thais Bergamin","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osmar Nascimento","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyla Caroline","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana Meira","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dielle de Oliveira","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Maria-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Brizolla","family":"Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Roberto Souza","family":"Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia Simalie","family":"Ombredane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celio","family":"de Faria Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia Skorupa","family":"Parachin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Simas","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oct\u00e1vio Luiz","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,6]]},"reference":[{"key":"BFja201677_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00203-011-0738-1","volume":"193","author":"GX He","year":"2011","unstructured":"He, G. X. et al. EmmdR, a new member of the MATE family of multidrug transporters, extrudes quinolones from Enterobacter cloacae. Arch. Microbiol. 193, 759\u2013765 (2011).","journal-title":"Arch. Microbiol."},{"key":"BFja201677_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/JCM.01263-11","volume":"50","author":"FC Yang","year":"2012","unstructured":"Yang, F. C., Yan, J. J., Hung, K. H. & Wu, J. J. Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital. J. Clin. Microbiol. 50, 223\u2013226 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"BFja201677_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1099\/jmm.0.038646-0","volume":"61","author":"I Heller","year":"2012","unstructured":"Heller, I., Grif, K. & Orth, D. Emergence of VIM-1-carbapenemase-producing Enterobacter cloacae in Tyrol, Austria. J. Med. Microbiol. 61, 567\u2013571 (2012).","journal-title":"J. Med. Microbiol."},{"key":"BFja201677_CR4","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1128\/JCM.00843-10","volume":"48","author":"M Panopoulou","year":"2010","unstructured":"Panopoulou, M. et al. Emergence of VIM-12 in Enterobacter cloacae. J. Clin. Microbiol. 48, 3414\u20133415 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"BFja201677_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ijantimicag.2010.01.011","volume":"35","author":"M Hornsey","year":"2010","unstructured":"Hornsey, M. et al. Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment. Int. J. Antimicrob. Agents 35, 478\u2013481 (2010).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFja201677_CR6","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1093\/jac\/dkr230","volume":"66","author":"SJ Nigro","year":"2011","unstructured":"Nigro, S. J. & Hall, R. M. GIsul2, a genomic island carrying the sul2 sulphonamide resistance gene and the small mobile element CR2 found in the Enterobacter cloacaesubspecies cloacae type strain ATCC 13047 from 1890, Shigella flexneri ATCC 700930 from 1954 and Acinetobacter baumannii ATCC 17978 from 1951. J. Antimicrob. Chemother. 66, 2175\u20132176 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja201677_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-642-28951-4_11","volume":"211","author":"AR Coates","year":"2012","unstructured":"Coates, A. R. & Halls, G. Antibiotics in phase II and III clinical trials. Handb. Exp. Pharmacol. 211, 167\u2013183 (2012).","journal-title":"Handb. Exp. Pharmacol."},{"key":"BFja201677_CR8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.2174\/138955711796575498","volume":"11","author":"M Zucca","year":"2011","unstructured":"Zucca, M., Scutera, S. & Savoia, D. New antimicrobial frontiers. Mini. Rev. Med. Chem. 11, 888\u2013900 (2011).","journal-title":"Mini. Rev. Med. Chem."},{"key":"BFja201677_CR9","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1128\/AAC.00834-10","volume":"54","author":"JH Moffatt","year":"2010","unstructured":"Moffatt, J. H. et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54, 4971\u20134977 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201677_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/0972-5229.58546","volume":"13","author":"S Gupta","year":"2009","unstructured":"Gupta, S. et al. Colistin and polymyxin B: a re-emergence. Indian J. Crit. Care Med. 13, 49\u201353 (2009).","journal-title":"Indian J. Crit. Care Med."},{"key":"BFja201677_CR11","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1128\/AAC.00169-13","volume":"57","author":"S Srivastava","year":"2013","unstructured":"Srivastava, S. & Ghosh, J. K. Introduction of a lysine residue promotes aggregation of temporin L in lipopolysaccharides and augmentation of its antiendotoxin property. Antimicrob. Agents Chemother. 57, 2457\u20132466 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201677_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fimmu.2012.00252","volume":"3","author":"SA David","year":"2012","unstructured":"David, S. A. Antimicrobial peptides for gram-negative sepsis: a case for the polymyxins. Front. Immunol. 3, 252 (2012).","journal-title":"Front. Immunol."},{"key":"BFja201677_CR13","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1021\/pr100740w","volume":"9","author":"XM Lin","year":"2010","unstructured":"Lin, X. M., Yang, J. N., Peng, X. X. & Li, H. A novel negative regulation mechanism of bacterial outer membrane proteins in response to antibiotic resistance. J. Proteome. Res. 9, 5952\u20135959 (2010).","journal-title":"J. Proteome. Res."},{"key":"BFja201677_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/nyas.12010","volume":"1277","author":"DM Shlaes","year":"2013","unstructured":"Shlaes, D. M. New beta-lactam-beta-lactamase inhibitor combinations in clinical development. Ann. N. Y. Acad. Sci. 1277, 105\u2013114 (2013).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFja201677_CR15","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1128\/AAC.02328-12","volume":"57","author":"K Naghmouchi","year":"2013","unstructured":"Naghmouchi, K. et al. Synergistic effect between colistin and bacteriocins in controlling gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob. Agents Chemother. 57, 2719\u20132725 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201677_CR16","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/jps.23508","volume":"102","author":"SJ Wallace","year":"2013","unstructured":"Wallace, S. J., Nation, R. L., Li, J. & Boyd, B. J. Physicochemical aspects of the coformulation of colistin and azithromycin using liposomes for combination antibiotic therapies. J. Pharm. Sci. 102, 1578\u20131587 (2013).","journal-title":"J. Pharm. Sci."},{"key":"BFja201677_CR17","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1128\/AAC.49.8.3136-3146.2005","volume":"49","author":"SK Kasiakou","year":"2005","unstructured":"Kasiakou, S. K. et al. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob. Agents Chemother. 49, 3136\u20133146 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"suppl 2","key":"BFja201677_CR18","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1086\/519256","volume":"45","author":"SK Olofsson","year":"2007","unstructured":"Olofsson, S. K. & Cars, O. Optimizing drug exposure to minimize selection of antibiotic resistance. Clin. Infect. Dis. 45 (suppl 2), S129\u2013S136 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"BFja201677_CR19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/jb.64.6.837-839.1952","volume":"64","author":"A Pomales-Lebron","year":"1952","unstructured":"Pomales-Lebron, A. & Fernandez, C. A method for estimating the number of bacteria in liquids and tissues. J. Bacteriol. 64, 837\u2013845 (1952).","journal-title":"J. Bacteriol."},{"key":"BFja201677_CR20","unstructured":"CLSI. in Approved Standard - 8th ed. CLSI document M07-A8 (Clinical and Laboratory Standards Institute, Wayne, PA, 2009)."},{"key":"BFja201677_CR21","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1021\/pr050159g","volume":"4","author":"X Peng","year":"2005","unstructured":"Peng, X. et al. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance. J. Proteome. Res. 4, 2257\u20132265 (2005).","journal-title":"J. Proteome. Res."},{"key":"BFja201677_CR22","doi-asserted-by":"publisher","first-page":"e88895","DOI":"10.1371\/journal.pone.0088895","volume":"9","author":"A Calderaro","year":"2014","unstructured":"Calderaro, A. et al. Identification of Borrelia species after creation of an in-house MALDI-TOF MS database. PLoS One. 9, e88895 (2014).","journal-title":"PLoS One."},{"key":"BFja201677_CR23","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1128\/JCM.00921-09","volume":"47","author":"A Mellmann","year":"2009","unstructured":"Mellmann, A. et al. High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J. Clin. Microbiol. 47, 3732\u20133734 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"BFja201677_CR24","unstructured":"CLSI. in Twentieth Informational Supplement CLSI document M100-S20 (Clinical and Laboratory Standards Institute, Wayne, PA, 2010)."},{"key":"BFja201677_CR25","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1128\/AAC.00922-10","volume":"54","author":"NC Gordon","year":"2010","unstructured":"Gordon, N. C., Png, K. & Wareham, D. W. Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 5316\u20135322 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201677_CR26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.biochi.2011.12.016","volume":"94","author":"C Lopez-Abarrategui","year":"2012","unstructured":"Lopez-Abarrategui, C. et al. Functional characterization of a synthetic hydrophilic antifungal peptide derived from the marine snail Cenchritis muricatus. Biochimie 94, 968\u2013974 (2012).","journal-title":"Biochimie"},{"key":"BFja201677_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/bip.22071","volume":"98","author":"ON Silva","year":"2012","unstructured":"Silva, O. N. et al. Cn-AMP1: a new promiscuous peptide with potential for microbial infections treatment. Biopolymers 98, 322\u2013331 (2012).","journal-title":"Biopolymers"},{"key":"BFja201677_CR28","doi-asserted-by":"publisher","first-page":"e5285","DOI":"10.1371\/journal.pone.0005285","volume":"4","author":"M Pasupuleti","year":"2009","unstructured":"Pasupuleti, M., Schmidtchen, A., Chalupka, A., Ringstad, L. & Malmsten, M. End-tagging of ultra-short antimicrobial peptides by W\/F stretches to facilitate bacterial killing. PLoS ONE 4, e5285 (2009).","journal-title":"PLoS ONE"},{"key":"BFja201677_CR29","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1128\/JCM.00518-13","volume":"51","author":"M Josten","year":"2013","unstructured":"Josten, M. et al. Analysis of the matrix-assisted laser desorption ionization-time of flight mass spectrum of staphylococcus aureus identifies mutations that allow differentiation of the main clonal lineages. J. Clin. Microbiol. 51, 1809\u20131817 (2013).","journal-title":"J. Clin. Microbiol."},{"key":"BFja201677_CR30","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s10096-012-1646-2","volume":"31","author":"A Kremer","year":"2012","unstructured":"Kremer, A. & Hoffmann, H. Prevalences of the Enterobacter cloacae complex and its phylogenetic derivatives in the nosocomial environment. Eur. J. Clin. Microbiol. Infect. Dis. 31, 2951\u20132955 (2012).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"BFja201677_CR31","doi-asserted-by":"publisher","first-page":"e3018","DOI":"10.1371\/journal.pone.0003018","volume":"3","author":"A Paauw","year":"2008","unstructured":"Paauw, A. et al. Genomic diversity within the Enterobacter cloacaecomplex. PLoS ONE 3, e3018 (2008).","journal-title":"PLoS ONE"},{"key":"BFja201677_CR32","first-page":"w13095","volume":"140","author":"M Risch","year":"2010","unstructured":"Risch, M. et al. Comparison of MALDI TOF with conventional identification of clinically relevant bacteria. Swiss Med. Wkly. 140, w13095 (2010).","journal-title":"Swiss Med. Wkly."},{"key":"BFja201677_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.eimc.2011.11.003","volume":"30","author":"JL Munoz Bellido","year":"2012","unstructured":"Munoz Bellido, J. L., Vega Castano, S., Ferreira, L., Sanchez Juanes, F. & Gonzalez Buitrago, J. M. Proteomic applications in the clinical microbiology laboratory. Enferm. Infecc. Microbiol. Clin. 30, 383\u2013393 (2012).","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"BFja201677_CR34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2217\/fmb.12.61","volume":"7","author":"ML Mezzatesta","year":"2012","unstructured":"Mezzatesta, M. L., Gona, F. & Stefani, S. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. Future Microbiol. 7, 887\u2013902 (2012).","journal-title":"Future Microbiol."},{"key":"BFja201677_CR35","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1128\/JCM.02321-10","volume":"49","author":"I Wybo","year":"2011","unstructured":"Wybo, I. et al. Differentiation of cfiA-negative and cfiA-positive Bacteroides fragilis isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49, 1961\u20131964 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"BFja201677_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijmm.2010.06.002","volume":"301","author":"M Wolters","year":"2011","unstructured":"Wolters, M. et al. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages. Int. J. Med. Microbiol. 301, 64\u201368 (2011).","journal-title":"Int. J. Med. Microbiol."},{"key":"BFja201677_CR37","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1248\/bpb.b12-00465","volume":"35","author":"M Muroi","year":"2012","unstructured":"Muroi, M., Shima, K., Igarashi, M., Nakagawa, Y. & Tanamoto, K. Application of matrix-assisted laser desorption ionization-time of flight mass spectrometry for discrimination of laboratory-derived antibiotic-resistant bacteria. Biol. Pharm. Bull. 35, 1841\u20131845 (2012).","journal-title":"Biol. Pharm. Bull."},{"key":"BFja201677_CR38","first-page":"10","volume":"52","author":"MV Malakhova","year":"2007","unstructured":"Malakhova, M. V. et al. MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones. Antibiot. Khimioter. 52, 10\u201317 (2007).","journal-title":"Antibiot. Khimioter."},{"key":"BFja201677_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijantimicag.2012.10.022","volume":"41","author":"M Hilty","year":"2013","unstructured":"Hilty, M. et al. Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy? Int. J. Antimicrob. Agents 41, 236\u2013249 (2013).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFja201677_CR40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1128\/AAC.50.4.1251-1256.2006","volume":"50","author":"JM Saugar","year":"2006","unstructured":"Saugar, J. M. et al. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action. Antimicrob. Agents Chemother. 50, 1251\u20131256 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201677_CR41","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1128\/AAC.05996-11","volume":"56","author":"C Vidaillac","year":"2012","unstructured":"Vidaillac, C., Benichou, L. & Duval, R. E. In vitrosynergy of colistin combinations against colistin-resistant Acinetobacter baumannii,Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. Antimicrob. Agents Chemother. 56, 4856\u20134861 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201677_CR42","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1128\/AAC.00753-15","volume":"59","author":"LM Phee","year":"2015","unstructured":"Phee, L. M. et al. Colistin and fusidic acid, a novel potent synergistic combination for treatment of multidrug-resistant Acinetobacter baumannii infections. Antimicrob. Agents Chemother. 59, 4544\u20134550 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201677_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/jac\/41.3.367","volume":"41","author":"O Mimoz","year":"1998","unstructured":"Mimoz, O. et al. Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae. J. Antimicrob. Chemother. 41, 367\u2013372 (1998).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja201677_CR44","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/AAC.48.3.1055-1057.2004","volume":"48","author":"R Jung","year":"2004","unstructured":"Jung, R., Husain, M., Choi, M. K. & Fish, D. N. Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae,Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrob. Agents Chemother. 48, 1055\u20131057 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201677_CR45","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000238286","volume":"30","author":"WH Traub","year":"1984","unstructured":"Traub, W. H., Haberle, R. & Bauer, D. Characterization of two clinical, multiple-drug-resistant isolates of Enterobacter cloacae. Chemotherapy 30, 308\u2013321 (1984).","journal-title":"Chemotherapy"},{"key":"BFja201677_CR46","first-page":"457","volume":"69","author":"OD Stefanovic","year":"2012","unstructured":"Stefanovic, O. D., Stanojevic, D. D. & Comic, L. R. Synergistic antibacterial activity of Salvia officinalis and Cichorium intybus extracts and antibiotics. Acta. Pol. Pharm. 69, 457\u2013463 (2012).","journal-title":"Acta. Pol. Pharm."},{"key":"BFja201677_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbapap.2005.10.019","volume":"1764","author":"Y Park","year":"2006","unstructured":"Park, Y. et al. Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells. Biochim. Biophys. Acta. 1764, 24\u201332 (2006).","journal-title":"Biochim. Biophys. Acta."},{"key":"BFja201677_CR48","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/jac\/39.3.363","volume":"39","author":"O Mimoz","year":"1997","unstructured":"Mimoz, O. et al. Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo. J. Antimicrob. Chemother. 39, 363\u2013369 (1997).","journal-title":"J. Antimicrob. Chemother."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ja201677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja201677","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja201677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T02:11:25Z","timestamp":1641003085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,6]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFja201677"],"URL":"https:\/\/doi.org\/10.1038\/ja.2016.77","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,6]]},"assertion":[{"value":"25 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}